The Latest Breaking News from diabetes

Usher will join French pharma giant Sanofi in Washington, D.C., to discuss the importance of early screening for type 1 diabetes.

Education about the risks of being overweight means nothing if people have no access to healthy food or places to exercise, says global public health expert Devi Sridhar

Most people are aware that the process of bringing new medical products to market is rigorous, complex and tightly regulated. Diagnostic tests, therapies and treatments all go through lengthy, expensive trials to make sure they’re safe and effective before being approved for public use. The gold standard for clinical trials…

Increasingly frequent natural disasters leave islanders reliant on processed foods for months on end – with deeply concerning knock-on effects to health

Increasing the daily intake of flavonoid-rich foods by one serving could reduce the risk of type 2 diabetes by 6%, the study revealed.

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has been shown in the SELECT Trial to be effective in preventing the loss of kidney function in people who are overweight or obese and have established cardiovascular disease but do not have diabetes. Read further on Dynamite News:

New research verifies the intuitive: That standing is better than sitting, exercise is great for overall health and getting good sleep is imperative.

Semaglutide injections reduce severe kidney outcomes and cardiovascular events in diabetes patients with chronic kidney disease. Early detection is crucial...

Semaglutide, the drug’s active ingredient, can dramatically decrease the prevalence of severe disease

Type 2 diabetes, typically associated with older people, has risen by 40 per cent in those aged under 40, Diabetes UK says

The report shows that the number of 12- to 25-year-olds using any GLP-1 drugs climbed by almost 600%